Publications

5054 Results

Genome-wide association studies of survival in 1,520 cancer patients treated with bevacizumab-containing regimens

Authors
J Quintanilha;J Wang;A Sibley;W Xu;O Espin-Garcia;C Jiang;A Etheridge;M Ratain;H-J Lenz;M Bertagnolli;H Kindler;M Dickler;A Venook;J Liu;K Owzar;D Lin;F Innocenti
Journal / Conference
International Journal of Cancer, Jan 15;150(2):279-289. doi: 10.1002/ijc.33810. Epub 2021 Oct 5
Year
2022
Research Committee(s)
Breast and Gastrointestinal
PMID
PMID34528705
Study Number(s)
CTSU/C40503, CTSU/C80405

The effect of metformin vs placebo on sex hormones in CCTG MA.32

Authors
I Pimentel;B Chen;A Lohman;M Ennis;J Ligibel;L Shepherd;D Hershman;T Whelan;V Stambolic;I Mayer;T Hobday;J Lemieux;A Thompson;P Rastogi;K Gelmon;D Rea;M Rabaglio;S Ellard;M Mates;P Bedard;L Petre;T Vandenberg;R Dowling;W Parulekar;P Goodwin
Journal / Conference
Journal of the National Cancer Institute Feb 1;113(2):192-198. doi: 10.1093/jnci/djaa082
Year
2021
Research Committee(s)
Breast
PMID
PMID32497219
PMC
PMC7850529

Mental Component score (MCS) from Health-related Quality of Life Predicts Incidence of Dementia in U.S. Males

Authors
X Ding;E Abner;F Schmitt;J Crowley;P Goodman;R Kryscio
Journal / Conference
Journal of Prevention of Alzheimer's Disease 8(2):169-174
Year
2021
Research Committee(s)
Prevention
PMID
PMID33569563
PMC
PMC8162937
Study Number(s)
S0000A

Improvement initiative to develop and implement a tool for detecting drug-drug interactions during oncology clinical trial enrollment eligibility screening

Authors
LA Marcath;T Coe;F Shakeel;E Reynolds;M Bayuk;S Haas;BG Redman;S-F Wong;DL Hertz
Journal / Conference
Journal of Patient Safety Jan 1;17(1):e28-e34. doi: 10.1097/PTS.0000000000000772; Sep 29. doi: 10.1097/PTS.0000000000000772. Online ahead of print
Year
2021
Research Committee(s)
Multiple sites
PMID
PMID33003175
PMC
PMC7775319

Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trial

Authors
K Albain;R Gray;D Makower;A Faghih;DF Hayes;C Geyer;E Dees;M Goetz;J Olson;T Lively;S Bavde;T Saphner;L Wagner;T Whelan;M Ellis;S Paik;W Wood;P Ravdin;M Keane;H Gomez;P Reddy;T Goggins;I Mayer;A Brufsky;D Toppmeyer;V Kaklamani;J Berenberg;J Abrams;G Sledge;J Sparano
Journal / Conference
Journal of the National Cancer Institute Apr 6;113(4):390-399
Year
2021
Research Committee(s)
Breast
PMID
PMID32986828

African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer

Authors
R Karunamuni;M Huynh-Le;C Fan;W Thompson;R Eeles;Z Kote-Jarai;C Tangen;P Goodman;IM Thompson;O Andreassen;A Dale;T Seibert
Journal / Conference
International Journal of Cancer Jan 1;148(1):99-105. Epub 2020 Sep 24.Sep 15. doi: 10.1002/ijc.33282. Online ahead of print
Year
2021
Research Committee(s)
Cancer Control and Prevention
PMID
PMID32930425
PMC
PMC8135907
Study Number(s)
S0000, SWOG-9217

An Intergroup Approach for Advanced Stage Classical Hodgkin Lymphoma (cHL) in Adolescents and Young Adults (AYA): SWOG S1826

Authors
S Castellino;M Leblanc;A Herrera;S Parsons;A Punnett;D Hodgson;S Rutherford;N Kahn;L Constine;K Davidson;A Prica;JW Friedberg;K Kelly
Journal / Conference
INTERNATIONAL SYMPOSIUM ON CHILDHOOD, ADOLESCENT AND YOUNG ADULT HODGKIN LYMPHOMA (ISCAYAHL) (5/13-16/20, Berlin, Germany)
Year
2021
Research Committee(s)
Lymphoma
Study Number(s)
S1826

Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance)

Authors
F Innocenti;A Sibley;S Patil;A Etheridge;C Jiang;F-S Ou;S Denning;G Casey;M Bertagnolli;H McLeod;T Auman;CD Blanke;Y Furukawa;A Venook;M Kubo;H-J Lenz;J Parker;M Ratain;K Owzar
Journal / Conference
Clinical Cancer Research Jan 1;27(1):267-275
Year
2021
Research Committee(s)
Gastrointestinal
PMID
PMID32958699
PMC
PMC7785628
Study Number(s)
CTSU/C80405

A Phase II Study of Telisotuzumab Vedotin (Teliso-V, Abbv-399) in Patients with C-Met Positive Stage I or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-Study SWOG S1400K, NCT03574753)

Authors
S Waqar;M Redman;SM Arnold;FR Hirsch;PC Mack;LH Schwartz;D Gandara;T Stinchcombe;S Ramalingam;S Tanna;R Raddin;K Minichiello;K Kelly;JD Bradley;RS Herbst;V Papadimitrakopoulou
Journal / Conference
Clinical Lung Cancer May;22(3):170-177. doi: 10.1016/j.cllc.2020.09.013. Epub 2020 Oct 14.
Year
2021
Research Committee(s)
Lung
PMID
PMID33221175
PMC
PMC8044254
Study Number(s)
S1400K

SWOG S1400A (NCT #02154490): A phase II study of Durvalumab for previously treated patients with stage IV squamous cell lung cancer (Lung-MAP sub-study)

Authors
H Borghaei;M Redman;K Kelly;S Waqar;F Robert;G Kiefer;P Stella;K Minichiello;D Gandara;RS Herbst;V Papadimitrakopoulou
Journal / Conference
Clinical Lung Cancer May;22(3):178-186. doi: 10.1016/j.cllc.2020.10.015. Epub 2020 Nov 10.
Year
2021
Research Committee(s)
Lung
PMID
PMID33358401
Study Number(s)
S1400A